TD ASSET MANAGEMENT INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2020$667,000
-28.4%
40,2000.0%0.00%0.0%
Q2 2020$931,000
+21.9%
40,200
-6.1%
0.00%0.0%
Q1 2020$764,000
+31.0%
42,800
+58.5%
0.00%0.0%
Q4 2019$583,000
-60.8%
27,000
-66.9%
0.00%
-50.0%
Q3 2019$1,487,000
-45.4%
81,618
+6.7%
0.00%
-50.0%
Q2 2019$2,723,000
-3.8%
76,518
-9.2%
0.00%0.0%
Q1 2019$2,830,000
+2.7%
84,241
+0.5%
0.00%
-20.0%
Q4 2018$2,755,000
-49.3%
83,814
-6.0%
0.01%
-37.5%
Q3 2018$5,433,000
+17.5%
89,119
-5.9%
0.01%
+14.3%
Q2 2018$4,624,000
-65.9%
94,693
-25.8%
0.01%
-66.7%
Q1 2018$13,561,000
+895.7%
127,620
+459.7%
0.02%
+950.0%
Q4 2017$1,362,000
+255.6%
22,800
+39.9%
0.00%
+100.0%
Q1 2017$383,000
+74.1%
16,300
-8.9%
0.00%
Q4 2016$220,000
-29.3%
17,900
-1.1%
0.00%
-100.0%
Q3 2016$311,000
+35.2%
18,100
-4.7%
0.00%
Q1 2014$230,000
+6.5%
19,0000.0%0.00%
Q4 2013$216,000
+20.7%
19,000
+11.1%
0.00%
Q3 2013$179,000
-9.6%
17,1000.0%0.00%
Q2 2013$198,00017,1000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders